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Limited Venoplasty and Anticoagulation Affords Excellent Long-Term
Results after First Rib Resection and Scalenectomy for Paget-
Schroetter Syndrome
Christopher J. Abularrage, Danielle H. Rochlin, Shalini Selvarajah, Ying W.
Lum, Julie A. Freischlag. Johns Hopkins Hospital, Baltimore, Md
Objectives: We have previously demonstrated excellent patency rates
following routine venography after ﬁrst rib resection and scalenectomy
(FRRS) for Paget-Schroetter syndrome. The goal of this study was to assess
the long-term outcomes of this technique.
Methods: Retrospective analysis of a prospectively collected database
was performed. Patients underwent routine venography 2 weeks post-
FRRS. Warfarin was discontinued in those with patent veins. Patients with
stenotic or occluded veins underwent attempted venoplasty with balloon
diameters approximating the size of the anatomically normal vein. Patients
with successful venoplasty or chronically occluded veins unable to be dilated
were continued on Warfarin up to 6 months. Follow-up duplex ultrasound
dictated cessation of anticoagulation. Kaplan-Meier analysis was performed
for primary, primary-assisted, and secondary patency.
Results: One-hundred ﬁfty-nine patients underwent FRRS and post-
operative venography with a median follow-up of 13.8 months. One patient
was lost to follow-up. At the time of venography, there were 42 patent, 72
stenotic, and 44 occluded veins. Of the 44 occlusions, 24 underwent veno-
plasty and 20 could not be crossed. In the entire group, restenosis occurred
in seven patients and reocclusion in seven. At last follow-up, six patients
remained occluded. Eighteen-month PP of venoplasty was 95.4 6 2.6% in
the stenotic group and 85.96 7.6% in the occluded group. Eighteen-month
primary-assisted patency of venoplasty was 98.36 1.7% in the stenotic group
and 96.06 7.5% in the occluded group. Overall secondary patency at 3 years
was 100% in the patent group, 98.46 1.6% in the stenotic group, and 97.46
2.6% in the occluded group.
Conclusions: Long-term venous patency rates after limited venoplasty
and anticoagulation following FRRS are excellent. Furthermore, prolonged
anticoagulation for occlusions that could not be crossed or in those that reoc-
clude after venoplasty results in recanalization and delayed patency. These
results argue against the need for stenting or open venous reconstruction, and
serve as a benchmark for the care of patients with Paget-Schroetter syndrome.
Ofﬁce-Based Iliac Venogram, IVUS, and Stenting
Anil Hingorani, Enrico Ascher, Borislav Kheyson, Arkady Ganelin, Eleanor
Iadgarova, Natalie Marks. Lutheran Medical Center, Brooklyn, NY
Objectives: The purpose of this study is to evaluate the safety and efﬁ-
cacy of ambulatory ofﬁce-based iliac vein venograms that were performed
for venous insufﬁciency.
Methods: Procedures were performed under local anesthesia with
puncture in the common femoral or femoral vein. Venogram and intravas-
cular ultrasound (IVUS) were performed of the inferior vena cava, iliac, and
femoral veins. Areas of 50% diameter or area reduction underwent stenting
and balloon angioplasty. Patients were followed with iliac duplex within 2
weeks and every 3 months, and were prescribed plavix to start the day after
the procedure. This series included 147 venograms combined with IVUS
from July 28, 2012 through November 20, 2012. Routine completion
venogram and IVUS were routinely obtained.
Results: Patient ages varied from 21 to 91 years old, with mean value
of 70 years old, with standard deviation of 613.18 years. Thirty percent of
patients underwent bilateral venograms, and 70% patients underwent unilat-
eral venogram based on clinical indications. Patients were classiﬁed using
clinical classiﬁcation of chronic lower extremity venous disease C1-C6
with total of C1-0, C2-121, C3-6, C4-0, C5-39, and C6-0. Ninety-one
percent of patients underwent stenting consistent with prior series. The
most common stents placed were 16 by 90 mm and 14- by 90-mm stents.
The average time for a procedure was 33.2 minutes with standard deviation
of 8.26 minutes. On subsequent follow-up, three patients had thrombosis of
the iliac vein stent requiring inpatient suction thrombectomy and lysistherapy. No restenosis was noted. No patient was admitted for anesthetic
complications, bleeding, or pain control.
Conclusions: These data suggest that this procedure can be performed
in an ambulatory ofﬁce setting safely and efﬁcaciously. The need for these
procedures to be performed as an inpatient needs to be re-examined.
Risk Factors for Nonretrieval of Retrievable Inferior Vena Cava Filters
Jeffrey J. Siracuse, Ahmed Al Bazroon, Andrew J. Meltzer, John Karwowski,
Darren Schneider, PeterH. Connolly. New York Presbyterian, New York, NY
Objectives: Optimal utilization of retrievable inferior vena cava (IVC)
ﬁlters is an important healthcare issue and despite an exponential rise in the
use of retrievable IVC ﬁlters, national trends suggest that themajority of these
ﬁlters are not removed. The purpose of this study was to identify risk factors
associated with nonretrieval of retrievable IVC ﬁlters at our institution.
Methods: A retrospective institutional review of all patients under-
going IVC ﬁlter placement from June 2010 to June 2012 was performed.
A number of patient parameters were studied, including relevant demo-
graphics, indication for ﬁlter placement, clinical history, related hospitaliza-
tion, and whether ﬁlter retrieval was performed. Patient parameters were
compared by univariate and multivariate logistic regression analysis.
Results: 605 (49% male) retrievable IVC ﬁlters were placed over a 24-
month period by vascular surgery, intervention radiology, and interventional
cardiology.One-hundred forty (23%) IVCﬁlterswere removed.By indication,
272 (45%), 53 (9%), and 280 (46%) ﬁlters were placed for absolute, relative,
and prophylactic indications, respectively. By univariate analysis, we examined
over 20 patient variables and identiﬁed 13 associated with nonretrieval (P <
.05). Independent predictors for nonretrieval by multivariate analysis were
age >80 (HR, 0.2; 95% CI, 0.05-0.6; P ¼ .005), acute bleed (HR, 0.4;
95% CI, 0.2-0.7; P ¼ .004), current malignancy (HR, 0.5; 95% CI, 0.3-0.8;
P ¼ .011), postﬁlter anticoagulation (HR, 2.0; 95% CI, 1.1-3.6; P ¼ .017),
and history of pulmonary embolism and venous thromboembolic event
(HR, 2.0; 95% CI, 1.2-3.5; P ¼ .007). Filter placement team and indication
were not identiﬁed as independent predictors of nonretrieval of IVC ﬁlters.
Conclusions: Patient variables identiﬁed by univariate and multivar-
iate analysis as risk for nonretrieval of retrievable IVC ﬁlters has several
implications: (1) some of these patients may represent a high-risk population
in which ﬁlter retrieval has diminishing returns and may indicate the clinical
option for permanence of the ﬁlter; and (2) identiﬁcation of risk factors for
nonretrieval in patients before ﬁlter placement will help to optimize utiliza-
tion of retrievable IVC ﬁlters and enhance retrieval rates.
Posterior Tibial Vein Aneurysm Presenting as Tarsal Tunnel
Syndrome: Case Report and Review of the Literature
Anu Whisenhunt, EnYaw Hong, Micheal Ayad, Josh Heller, Babak Abai,
Dawn Salvatore, Paul DiMuzio. Thomas Jefferson University Hospital,
Philadelphia, Pa
Objectives: To describe the ﬁrst case of tarsal tunnel syndrome asso-
ciated with an aneurysm of the posterior tibial vein.
Methods: Tarsal tunnel syndrome is a compressive neuropathy of the
posterior tibial nerve in the medial aspect of the ankle. The etiology of this
pathology is varied and different. It includes space occupying lesions, trauma,
inﬂammation, anatomic deformity, iatrogenic injury, idiopathic, and systemic
causes. We performed an extensive literature review and present a case report
on tarsal tunnel syndrome from a venous aneurysm which was misdiagnosed
as a nerve sheath tumor on magnetic resonance imaging.
Results: A 46-year-old male presented to our hospital with chronic
history of left foot pain and swelling. Initial imaging with magnetic reso-
nance imaging suggested a nerve sheath tumor; however, subsequent ultra-
sound revealed this to be a venous aneurysm, measuring 2.0  0.7  0.7 cm
(posterior venous concomitant) impinging on the posterior tibial nerve, Figs
1 and 2. Through an open approach, we ligated and resected the venous
aneurysm (Fig 3) along with lysing the peripheral nerve. At follow-up (1
month), he has had complete resolution of his pain.
Conclusions: This case represents the ﬁrst report of a venous aneu-
rysm resulting in compression of the tibial nerve at the level of the malleolus
resulting in pain. Surgical decompression has been curative.1145
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Fig 2. Ultrasound imaging of tarsal tunnel.
Fig 3. Posterior tibial vein aneurysm.Iliac Vein Angioplasty Augments Venous Ulcer Healing in Patients
who have Standard Compression Therapy and Perforator Closure
Albeir Y. Mousa, Mike Broce, Shadi Abu-Halimah, Saadi Alhalbouni, Betro
Sadek, Stephen M. Hass, John E. Campbell, Patrick A. Stone, Ali F.
AbuRahma. R. C. Byrd Health Sciences Center, West Virginia University,
Charleston, WV
Objectives: Treatment of venous ulcers is demanding for patients as
well as clinicians, and treatment of underlying venous hypertension is the
cornerstone of therapy. We propose that iliac vein angioplasty and stenting
(IVAS) augment healing of venous ulcers in selected patients.
Methods: We conducted a retrospective review of all prospectively
collected data from patients with CEAP 6 venous disease. Patient demo-
graphics, comorbidities, venous reﬂux studies, and ulcer description were
analyzed. Iliac vein stenosis was deﬁned as $50% stenosis on intravascular
ultrasound. All patients had great saphenous vein ablation, in addition to
conservative treatment, including Unna boot compression, and perforator
closure using ablation therapy.
Results: Seventeen patients with CEAP 6 venous disease and ulcers
greater than 1.5 cm in diameter were included. The average age was 63
6 10 years of age, and the majority were female (70.6%) with common
comorbidities such as hyperlipidemia (47.1%), hypertension (35.3%) and
diabetes (23.5%). All patients had arterial duplex evaluations to rule out
associated peripheral vascular disease. Twenty-four ulcers with an average
diameter of 3.1 6 0.9 cm and depth 2.2 6 0.5 cm were treated. Perforator
venous reﬂux was 3.66 0.8 seconds with diameter estimated at 3.76 2 mm
performed in an accredited vascular laboratory. The majority (n ¼ 15;
62.5%) of the perforator veins were located at the base of the ulcer, whereas
the remainder (n ¼ 9; 32.5%) were within 2 cm from the base. Seven
(29.2%) of the 24 ulcers did not respond to the conventional therapy; all
were found to have signiﬁcant iliac vein stenosis and were treated with
IVAS. Ulcer healing time was shorter in IVAS group (3.9 6 1.5 weeks)
than those patients receiving only perforator and Unna boot treatment
(7.9 6 9.2 weeks), although this difference was not statistically signiﬁcant
(P ¼ .223), which was directly attributed to sample size. Two patients,
one in each group, experienced ulcer recurrence (P ¼ .507).
Conclusions: The early results from this study suggest that venous
ulcer healing can be augmented with iliac vein angioplasty/stenting. The
majority of underlying perforators were found under or within 2 cm from
the venous ulcer. However, our early results should be viewed with caution
because of the small sample size. Further studies are needed to deﬁne the
exact role of iliac vein angioplasty/stenting in patients with venous ulcers.
Aromatase Deletion Accelerates Female Experimental Abdominal
Aortic Aneurysm Formation
William Forrest Johnston, Gang Su, Morgan Salmon, Guanyi Lu, Emilie F.
Rissman, Gorav Ailawadi, Gilbert Rivers Upchurch Jr. University of
Virginia, Charlottesville, Va
Objectives: The protective effects of female sex on the development
of abdominal aortic aneurysms (AAAs) have been attributed to the anti-
inﬂammatory effects of estrogen. All estrogen synthesis depends on the
enzyme aromatase, which is located centrally in the ovaries, as well as
peripherally in adipose tissue, bone, and vascular smooth muscle cells. We
hypothesized that aromatase genetic deletion would diminish the protective
effect of female sex and would be associated with increased aortic diameter
in female mice.
Methods: Female 8- to 10-week-old mice with aromatase (wild type:
WT) and without aromatase (ArKO) underwent elastase aortic perfusion.
WT male mice underwent elastase perfusion as a positive control. To eval-
uate the contribution of peripheral estrogen conversion, female WT and
ArKO mice that had undergone ovariectomy (ovx) at 6 weeks were perfused
with elastase. Thus, four groups of female mice were compared: WT, ArKO,
WT ovx, and ArKO ovx. At aortic harvest, maximal aortic dilations, aortic
inﬂammatory cytokines, and serum estradiol concentrations were compared
with analysis of variance.
Results: Female WT mice had signiﬁcant reduction in aortic dilation
compared with male WT mice (F WT: 51.15.9% vs M WT: 79.3 1.6%; P <
.005). The protective effects of female sex were mostly overcome with ovari-
ectomy (WT ovx: 70.64.1%; P < .05 vs F WT) and completely eliminated
with deletion of aromatase (ArKO: 78.57.8%; P < .05 vs F WT). Peripheral
estrogen conversion accounted for 30% of the protective effect of female sex.
Female mice with both aromatase deletion and ovariectomy had the largest
aortic dilation (87.35.6%; P < .001 vs F WT and P < .05 vs WT ovx).
Concordantly, female ArKO ovx mice had signiﬁcantly higher levels of proin-
ﬂammatory cytokines Monocyte chemotactic protein-1 and interleukin-1. As
expected, deletion of aromatase or ovariectomy was associated with
decreased serum estradiol levels with a direct correlation between decreasing
estradiol levels and increasing aortic dilation (R ¼ 0.465; P < .05).
